Evgen Pharma (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, this morning announced a new research collaboration with Imperial College London
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced the following update on the screening at the University
Evgen Pharma (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, this morning announced that the results of mechanistic studies into SFX-01, the
Evgen Pharma Plc (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced a collaboration with King’s College London (“King’s”) to
Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to modulate key signalling pathways
Evgen Pharma Plc (LON:EVG) is the topic of conversation when Vadim Alexandre, Head of Research at Northland Capital Partners joins DirectorsTalk. With Evgen proving it’s interim results and notice of
Evgen Pharma PLC (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced it has conditionally raised £2.3 million (before expenses)
Stephen Franklin, Chief Executive Officer of Evgen Pharma, said: “We are particularly pleased with the progress of the STEM trial and the requirement to open the compassionate use programme for
Evgen Pharma (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has told DirectorsTalk about the grant of the first European patent for
Evgen Pharma PLC (LON:EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that it has received notice to exercise options over 837,600
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
